Latest News

Wednesday, May 27, 2015 | Conferences, Prevent Blindness

Prevent Blindness to Hold 10th Annual Eyes on Capitol Hill Event

Prevent Blindness will be holding its 10th annual “Eyes on Capitol Hill” program on Tuesday, June 16, 2015, in Washington, DC, according to a company news release. The program provides cit…

Read the full story

Wednesday, May 27, 2015 | Medical Studies

Vision Problems Rare in Children With Dyslexia

A large, cross-sectional British study of almost 7000 children aged 7 to 9 years has confirmed previous findings that visual impairment is rarely the cause of pediatric reading problems. Hence, the st…

Read the full story

Tuesday, May 26, 2015 | Retina, Ocata Therapeutics

Ocata Therapeutics Receives Three New U.S. Patents for its RPE Therapy for Macular Degenerative Diseases

Ocata Therapeutics announced that the United States Patent and Trademark Office issued three new US Patents (Nos. 9,040,770, 9,040,039 and 9,040,038) that expand the scope of protection of the fo…

Read the full story

Tuesday, May 26, 2015 | Cataract Surgery, Omeros

EU Regulators Approve Omidria for Lens Replacement Surgery

European Union (EU) drug regulators have recommended approval of phenylephrine and ketorolac injection (Omidria, Omeros) for lens replacement eye surgery. Phenylephrine maintains intraoperative mydria…

Read the full story

Tuesday, May 26, 2015 | Miscellaneous

Ocumetics: This Lens Could Give You Superhuman Vision

Ocumetics Technology Corp. claims to have developed a painless eight-minute procedure that would give you vision that is supposedly three times better than 20/20. The "bionic" lenses wo…

Read the full story

Tuesday, May 26, 2015 | Product Releases, Nidek

Nidek Launches GYC-500 Vixi and GYC-500 Laser Photocoagulator

Nidek has announced the launch of the GYC-500 Vixi Green Scan Laser Photocoagulator / GYC-500 Green Laser photocoagulator, according to a company news release. The GYC-500 Vixi / GYC-500 is a so…

Read the full story

Friday, May 22, 2015 | Medical Studies

Diabetes: Personalized Care During Eye Checks Has No Benefit

Adding personalized education and risk assessment to routine eye exams does not improve glycemic control among patients with diabetes, according to a randomized trial conducted by the Diabetic Retinop…

Read the full story

Friday, May 22, 2015 | Earnings & Financials, I-Optics

i-Optics Closes 13.7 Million Euro Financing Round

i-Optics announced that it has closed a new financing round, securing 13.7 million euro equity from existing and new investors, according to a company news release. With this new injection of capital,…

Read the full story

Friday, May 22, 2015 | Medical Studies

Electronic Prescriptions Up, but Not Prescribers

The number of electronic prescriptions continues to increase, but the number of physicians and other prescribers writing them has leveled off, according to the latest data from Surescripts, the compan…

Read the full story

Thursday, May 21, 2015 | Clinical Trials

Isarna Announces Orphan Drug Designation in the European Union for ISTH0036 to Treat Advanced-Stage Glaucoma

Isarna Therapeutics announced that the European Medicines Agency (EMA) has granted orphan drug designation for ISTH0036, a locked nucleic acid-modified antisense oligonucleotide, for the prevention of…

Read the full story

Thursday, May 21, 2015 | Medical Studies

Scientists Look at 'The Dress' and Answer the Color Conundrum

Black and blue or white and gold? That is the question that took the world by storm back in February after two friends from Scotland posted a picture of a dress online seeking an answer because they d…

Read the full story

Thursday, May 21, 2015 | Medical Studies

Novel Anticoagulants May Not Boost Intraocular Bleeding Risk

Compared to other antithrombotic drugs, novel oral anticoagulants (NOACs) do not pose an extra risk of substantial intraocular bleeding, according to Portuguese researchers. As Dr. Daniel Caldeira tol…

Read the full story

Thursday, May 21, 2015 | Management/Leadership, GrayBug

GrayBug Announces Leadership Transition

GrayBug announced that Jeffrey L. Cleland, PhD, will assume the role of interim chief executive officer, according to a company news release. Christy Shaffer, PhD, managing director of Hatteras Discov…

Read the full story

Wednesday, May 20, 2015 | Earnings & Financials

ClarVista Medical Completes $14 Million Series B Financing to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement

ClarVista Medical, developer of the Harmoni system, a modular and exchangeable IOL for lens replacement after cataract surgery, announced that it has secured $14 million in Series B financing,…

Read the full story

Wednesday, May 20, 2015 | Medical Studies

Risk of Surgeries May Offset Benefit of Intraocular Lens in Infants

A higher risk of multiple surgeries may offset any advantages to implanted intraocular lenses (IoLs) after cataract surgery in infants, a new study has found. "Our findings regarding early outcom…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $10.89  2.54% 
 Akorn, Inc. $43.96  2.61% 
 Alimera Sciences, Inc. $4.37  3.07% 
 Allergan, Inc. $240.22  0.00% 
 Avalanche $39.13  5.70% 
 Bayer $146.76  1.56% 
 Can-Fite Biopharma $2.31  0.00% 
 Carl Zeiss Meditec $21.75  -1.16% 
 Cooper Companies, Inc. $179.18  0.01% 
 Escalon Medical Corp. $1.46  0.69% 
 Essilor International $121.75  -1.02% 
 Imprimis Pharmaceuticals, Inc. $8.47  -0.35% 
 InSite Vision, Inc. $0.13  -7.33% 
 IRIDEX Corporation $8.93  -2.40% 
 Johnson & Johnson $101.13  0.31% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $66.91  2.48% 
 Merck & Company, Inc. $59.46  0.83% 
 NicOx $1.86  -0.43% 
 NovaBay Pharmaceuticals, Inc. $0.74  5.36% 
 Novartis AG Common Stock $103.53  1.69% 
 Ocular Therapeutix $24.35  3.18% 
 Ophthotech Corporation $48.25  -7.43% 
 Quantel $3.08  0.33% 
 Regeneron $515.37  1.73% 
 Roche $36.89  1.81% 
 STAAR Surgical Company $9.42  2.95% 
 TearLab Corporation $2.39  1.27% 
 Thrombogenics $5.80  0.00% 
 Topcon Corporation $26.20  0.00% 
 Valeant Pharmaceuticals $239.12  1.62% 
 Xoma $3.32  -1.19%